LifeMD (NASDAQ:LFMD) CMO Jessica Friedeman Sells 15,000 Shares

LifeMD, Inc. (NASDAQ:LFMD) CMO Jessica Friedeman sold 15,000 shares of the company’s stock in a transaction on Tuesday, December 9th. The stock was sold at an average price of $3.61, for a total value of $54,150.00. Following the sale, the chief marketing officer directly owned 205,000 shares in the company, valued at $740,050. This represents a 6.82% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

LifeMD Trading Down 4.2%

Shares of LifeMD stock traded down $0.15 during trading on Thursday, reaching $3.46. The company’s stock had a trading volume of 1,213,902 shares, compared to its average volume of 1,517,511. The firm has a market cap of $166.56 million, a PE ratio of -20.35 and a beta of 1.36. The company has a 50-day moving average price of $5.20 and a two-hundred day moving average price of $8.05. LifeMD, Inc. has a fifty-two week low of $3.42 and a fifty-two week high of $15.84.

LifeMD (NASDAQ:LFMD) last issued its quarterly earnings data on Monday, November 17th. The company reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.04). The company had revenue of $60.17 million for the quarter, compared to analysts’ expectations of $62.07 million. During the same quarter last year, the firm posted $0.09 earnings per share. On average, analysts predict that LifeMD, Inc. will post -0.56 earnings per share for the current fiscal year.

Hedge Funds Weigh In On LifeMD

Several institutional investors and hedge funds have recently modified their holdings of the business. Nisa Investment Advisors LLC raised its holdings in LifeMD by 148.5% during the second quarter. Nisa Investment Advisors LLC now owns 3,656 shares of the company’s stock worth $50,000 after acquiring an additional 2,185 shares in the last quarter. Tower Research Capital LLC TRC boosted its position in shares of LifeMD by 110.4% in the second quarter. Tower Research Capital LLC TRC now owns 4,674 shares of the company’s stock valued at $64,000 after acquiring an additional 2,452 shares during the period. Caitong International Asset Management Co. Ltd raised its holdings in LifeMD by 1,004.9% in the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 5,171 shares of the company’s stock valued at $70,000 after acquiring an additional 4,703 shares in the last quarter. Quarry LP acquired a new stake in shares of LifeMD during the 3rd quarter worth approximately $52,000. Finally, Baader Bank Aktiengesellschaft bought a new position in LifeMD in the 2nd quarter valued at approximately $136,000. 35.52% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on LFMD shares. Loop Capital set a $8.00 target price on LifeMD in a research report on Monday, November 24th. HC Wainwright cut their price target on shares of LifeMD from $13.00 to $9.00 and set a “buy” rating for the company in a report on Wednesday, November 19th. Wall Street Zen lowered shares of LifeMD from a “hold” rating to a “sell” rating in a report on Saturday, November 22nd. Zacks Research lowered shares of LifeMD from a “hold” rating to a “strong sell” rating in a research report on Thursday, November 20th. Finally, BTIG Research cut their price objective on shares of LifeMD from $18.00 to $10.00 and set a “buy” rating on the stock in a research report on Tuesday, November 18th. Six investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $9.25.

LifeMD Company Profile

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.